Health Canada drug identification number

DIN 02016109 — SURVANTA 25 MG

SURVANTA is a suspension of Beractant marketed by ABBVIE CORPORATION. The full Beractant monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02016109
Brand name
SURVANTA
Active ingredient
Beractant
Strength
25 MG
Dosage form
SUSPENSION
Route
INTRATRACHEAL
Manufacturer
ABBVIE CORPORATION
Health Canada status
MARKETED
Drug class
Pulmonary surfactant

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.